In this question-and-answer interview, Andrew Billington (shown), operations manager at Brecon Pharmaceuticals in Wales, addresses recent trends in packaging. What is he looking for in new packaging machinery? Billington says: "Quicker changeover and anything that facilitates GMPs [Good Manufacturing Practices] are at the top of the list. Both are especially important for a contract packager because our runs can be quite short. Added changeover pressure can also come from the multiple languages we deal with here in Europe. That’s something our counterparts in the United States do not have to face."
Question: Do you have any particular strategy for coping with the need for such versatility?
Billington: We work very hard at what we call late-stage customization. Essentially it boils down to a fairly generic blister-pack that you customize for specific language requirements only at the end. The carton and the leaflet insert, and perhaps the labeling on the carton, are the components that get customized the most.
Question: What has changed in pharmaceutical packaging in the past few years?
Billington: We’re seeing greater reliance on electronic systems to identify product quality and to verify product ID. There used to be considerably less of this outside of the sterile side of pharmaceutical packaging, where it’s been ongoing for some time. But now we’re seeing it more on the relatively straightforward blister-pack business, too.
Question: What about counterfeiting?
Billington: As contract packagers, it’s a bit less of an issue for us since we don’t own the product or brand. We use the packaging designed by our customers. But we are beginning to see holograms, microprinting, and other such technologies with greater frequency.
Question: Any changes in materials worth noting?
Billington: We are definitely seeing a movement toward more sophisticated laminations aimed at lengthening shelf life. Also, a third of the work we do is cold-form foil as opposed to thermoformed materials. Five years back, it would only have been about five- to ten-percent cold-formed foil. Fortunately, we’ve come up with some proprietary developments in cold-forming tools to keep their cost down.
Source: healthcare-packaging
Question: Do you have any particular strategy for coping with the need for such versatility?
Billington: We work very hard at what we call late-stage customization. Essentially it boils down to a fairly generic blister-pack that you customize for specific language requirements only at the end. The carton and the leaflet insert, and perhaps the labeling on the carton, are the components that get customized the most.
Question: What has changed in pharmaceutical packaging in the past few years?
Billington: We’re seeing greater reliance on electronic systems to identify product quality and to verify product ID. There used to be considerably less of this outside of the sterile side of pharmaceutical packaging, where it’s been ongoing for some time. But now we’re seeing it more on the relatively straightforward blister-pack business, too.
Question: What about counterfeiting?
Billington: As contract packagers, it’s a bit less of an issue for us since we don’t own the product or brand. We use the packaging designed by our customers. But we are beginning to see holograms, microprinting, and other such technologies with greater frequency.
Question: Any changes in materials worth noting?
Billington: We are definitely seeing a movement toward more sophisticated laminations aimed at lengthening shelf life. Also, a third of the work we do is cold-form foil as opposed to thermoformed materials. Five years back, it would only have been about five- to ten-percent cold-formed foil. Fortunately, we’ve come up with some proprietary developments in cold-forming tools to keep their cost down.
Source: healthcare-packaging
No comments:
Post a Comment